JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2701
CALL
argenx
ARGX
$57.5B
| $9.22M | ﹤0.01% |
+15,000
| New | +$8.79M |
2024 Q4
0 quarters
|
|
|
2702
PUT
argenx
ARGX
$57.5B
| $9.22M | ﹤0.01% |
15,000
+14,400
| +2,400% | +$8.44M |
2024 Q3
1 quarter
|
|
2703
BlueLinx
BXC
$579M
| $9.2M | ﹤0.01% |
90,073
-2,071
| -2% | -$237K |
2017 Q2
30 quarters
|
|
2704
Columbia EM Core ex-China ETF
XCEM
$2.17B
| $9.19M | ﹤0.01% |
310,558
-5,344
| -2% | -$169K |
2023 Q4
4 quarters
|
|
2705
Douglas Dynamics
PLOW
$935M
| $9.19M | ﹤0.01% |
388,987
-693,448
| -64% | -$17.6M |
2013 Q2
46 quarters
|
|
2706
ePlus
PLUS
$2.44B
| $9.18M | ﹤0.01% |
124,251
+69,410
| +127% | +$6.06M |
2016 Q2
34 quarters
|
|
2707
Cleveland-Cliffs
CLF
$6.46B
| $9.18M | ﹤0.01% |
976,512
-283,497
| -22% | -$3.42M |
2013 Q2
46 quarters
|
|
2708
ManpowerGroup
MAN
$2.52B
| $9.15M | ﹤0.01% |
158,577
-3,957
| -2% | -$252K |
2013 Q2
46 quarters
|
|
2709
Shoals Technologies Group
SHLS
$1.4B
| $9.13M | ﹤0.01% |
1,650,819
-4,587,158
| -74% | -$23.3M |
2021 Q1
15 quarters
|
|
2710
St. Joe Company
JOE
$3.72B
| $9.12M | ﹤0.01% |
202,911
+50,346
| +33% | +$2.6M |
2013 Q2
46 quarters
|
|
|
AAMI
2711
Acadian Asset Management
AAMI
$3.34B
| $9.11M | ﹤0.01% |
345,748
+81,075
| +31% | +$2.27M |
2016 Q4
32 quarters
|
|
2712
Roivant Sciences
ROIV
$25.8B
| $9.09M | ﹤0.01% |
768,489
-54,093
| -7% | -$640K |
2022 Q2
10 quarters
|
|
2713
Invesco Dorsey Wright Momentum ETF
PDP
$1.5B
| $9.09M | ﹤0.01% |
84,464
+381
| +0.5% | +$41.8K |
2013 Q2
46 quarters
|
|
|
PPBI
2714
DELISTED
Pacific Premier Bancorp
PPBI
| $9.09M | ﹤0.01% |
364,604
+214,069
| +142% | +$5.67M |
2016 Q4
32 quarters
|
|
2715
PUT
CVS Health
CVS
$111B
| $9.06M | ﹤0.01% |
201,900
-93,400
| -32% | -$5.24M |
2021 Q2
14 quarters
|
|
|
B
2716
CALL
Barrick Mining
B
$66.2B
| $9.06M | ﹤0.01% |
584,600
+200,000
| +52% | +$3.64M |
2023 Q1
7 quarters
|
|
2717
PUT
Lucid Motors
LCID
$1.63B
| $9.06M | ﹤0.01% |
300,000
+276,990
| +1,204% | +$7.21M |
2024 Q3
1 quarter
|
|
2718
O-I Glass
OI
$860M
| $9.04M | ﹤0.01% |
833,620
+213,977
| +35% | +$2.6M |
2013 Q2
46 quarters
|
|
2719
Criteo S.A.
CRTO
$722M
| $9.03M | ﹤0.01% |
228,301
-109,579
| -32% | -$4.37M |
2014 Q2
42 quarters
|
|
2720
OneMain Financial
OMF
$6.44B
| $9.02M | ﹤0.01% |
172,988
-1,183
| -0.7% | -$61.3K |
2017 Q4
28 quarters
|
|
2721
State Street SPDR S&P Health Care Equipment ETF
XHE
$189M
| $9.02M | ﹤0.01% |
101,858
+317
| +0.3% | +$28.5K |
2017 Q2
30 quarters
|
|
2722
Harmonic Inc
HLIT
$1.22B
| $9.02M | ﹤0.01% |
681,425
+434,481
| +176% | +$5.67M |
2013 Q2
46 quarters
|
|
2723
AMC Entertainment Holdings
AMC
$2.47B
| $9.01M | ﹤0.01% |
2,263,513
+1,081,464
| +91% | +$4.75M |
2015 Q4
36 quarters
|
|
2724
PUT
Regions Financial
RF
$23.1B
| $9M | ﹤0.01% |
382,600
+600
| +0.2% | +$14.8K |
2024 Q2
2 quarters
|
|
2725
Sprott Physical Gold
PHYS
$14.8B
| $8.99M | ﹤0.01% |
446,623
+51,334
| +13% | +$1.06M |
2021 Q1
15 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.